Mortality in Parkinson's disease: a systematic review and meta-analysis.
about
Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness AnalysisIncreased risk of Parkinson disease in patients with carbon monoxide intoxication: a population-based cohort studyThe clinical symptoms of Parkinson's disease.Mortality in Iranian Patients with Parkinson's Disease: Cumulative Impact of Cardiovascular Comorbidities as One Major Risk Factor14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening.Clinical and Epidemiological Factors Associated with Mortality in Parkinson's Disease in a Brazilian Cohort.Co-morbidity burden in Parkinson's disease: Comparison with controls and its influence on prognosis.National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers.The Impact of Dysphagia Therapy on Quality of Life in Patients with Parkinson's Disease as Measured by the Swallowing Quality of Life Questionnaire (SWALQOL).Mortality and Its Risk Factors in Patients with Rapid Eye Movement Sleep Behavior Disorder.Computer keyboard interaction as an indicator of early Parkinson's diseaseProspective comorbidity-matched study of Parkinson's disease and risk of mortality among women.Predictors of functional dependency in Parkinson's disease.Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls.Levodopa: effect on cell death and the natural history of Parkinson's disease.Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.A systematic review of loss of independence in Parkinson's disease.Cellular models for Parkinson's disease.Current and experimental treatments of Parkinson disease: A guide for neuroscientists.Fall-related hospitalization in people with Parkinson's disease.Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.Risk Factors for Hip Fracture in Older Men: The Osteoporotic Fractures in Men Study (MrOS).Progressive supra-nuclear palsy: frequency of cardinal extrapyramidal features at first presentation.Benefit from the Chin-Down Maneuver in the Swallowing Performance and Self-Perception of Parkinson's Disease Patients.Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.Development and validation of prognostic survival models in newly diagnosed Parkinson's disease.Living and dying with Parkinson's disease.Doesn't subthalamic nucleus deep brain stimulation have a neuroprotective effect in Parkinson's disease patients?Pimavanserin: A novel therapeutic option for Parkinson disease psychosis.Mortality and quality of death certification in a cohort of patients with Parkinson's disease and matched controls in North Wales, UK at 18 years: a community-based cohort study.Impaired Quality of Life and Need for Palliative Care in a German Cohort of Advanced Parkinson's Disease Patients.Video-fluoroscopic swallowing study scale for predicting aspiration pneumonia in Parkinson's disease.Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression
P2860
Q26779605-E48D1839-A7B4-443B-8352-B68176CE3500Q28390984-0F206B51-1F17-49DF-B1F7-DB7B985E4704Q34533843-4F7DCA39-DF90-495E-AB65-1B185386F7D8Q36242256-7EF1B613-E34C-43C3-BF6B-6F8AE66D111BQ36402571-27F493A6-69D0-4634-9471-A84DC86C8156Q36447155-00F37B3F-9037-4B2E-B44B-92F33D066569Q37048315-BB6348A6-9D8B-4883-9881-215E73ED8593Q37081102-FE7CBBF8-6CA2-4E4D-B0E4-A4A0A34BBBC0Q37088511-BF17B59E-4CED-4F71-B03C-BA7545550E27Q37095501-2D124E35-8B9F-4A82-92F0-561CEF837B30Q37310810-59CF0A56-56F1-4DA7-898C-9EC80CD2CBD2Q37312347-E54EE989-F602-4419-B9AD-97AF1D5D8AC3Q37371148-7C35E5A2-892C-418B-A5D8-51617CBC0B3AQ37415178-BADD9114-7C56-41CB-97C8-E3680D787AD6Q38287219-59E3E635-A271-4F84-92B3-7DCA24DB2938Q38373533-C7E7F4F2-28A5-4718-9E34-1A768296809DQ38547146-B0C3FC62-F63B-418D-A59E-5D67311DB183Q38777301-01279178-1CEB-4B29-9F9E-8F73C60AADE8Q38941557-E9BBD2DE-A907-4CAB-ADF3-E47C6BDCA514Q39002287-D614B731-455C-4982-8D7A-AC851D19D46CQ39386374-43255A02-9C19-47D8-85E5-95387DF2FD35Q40534297-BD491FED-3D2B-42B4-8A94-D12853A4C6A6Q40949767-8CF7325D-B1F1-4A0B-8425-578DBAAFE1AEQ42324578-9E762636-6D95-4517-9DEB-2E3524337CBFQ47338262-83618465-0D95-42E0-80E2-3CBFDF7C0532Q48247382-962C8432-758A-48FF-813E-BF2E4BD10A4FQ48250448-1A913ECE-9E54-4423-AF91-839EC30C950BQ48285136-C4BCC2FE-FF6B-4DB6-8310-538E543E74D4Q49556672-ED48B470-E8C6-4BED-B6F8-ABC45EFE7E7FQ49996617-4EA691B5-E5DA-4E89-80B1-02EE724176F6Q55176226-801D790A-144D-497A-879A-FC479B51E0C3Q55300013-80853918-89B5-4C24-9CF3-0A9F067D8038Q55618860-9B5EA64D-910D-4A39-B127-826FDA51B452Q57058859-5CAA94E3-2CC9-43E7-9C2E-F8AA8F43E2B9Q58780873-6099724F-CB3F-4B2F-95D4-BD541D3CF119
P2860
Mortality in Parkinson's disease: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mortality in Parkinson's disease: a systematic review and meta-analysis.
@en
type
label
Mortality in Parkinson's disease: a systematic review and meta-analysis.
@en
prefLabel
Mortality in Parkinson's disease: a systematic review and meta-analysis.
@en
P2860
P356
P1433
P1476
Mortality in Parkinson's disease: a systematic review and meta-analysis.
@en
P2093
Carl E Counsell
Kate S M Taylor
P2860
P304
P356
10.1002/MDS.25898
P407
P577
2014-05-13T00:00:00Z